Associate Cohort Representative/Member, 09/2023 to Current
(2NA) Second-entry Nursing Association/York University – Toronto, ON
Cohort Representative/Member Responsibilities:
· Serves the second-entry students in connecting them with the Nursing Students Association of York (NSAY), the YU Student Nurse Mentorship Program (YUSNMP), the Registered Nurses’ Association of Ontario (RNAO), and the Canadian Nursing Students’ Association (CNSA) as well as the School of Nursing (SoN)
· Establishes communication and acts as a liaison between the students and faculty, as well as NSAY/2NA/NSTAMP
· Recognizes of the needs of students and facilitates their advocacy
· Makes in-class announcements for second-entry students for the promotion of 2NA events
· Attends of monthly meetings with UPD with the Lead Cohort
· Attends biweekly 2NA Board meetings
Nursing Student Membership, 01/2024 to Current
Registered Nurses' Association of Ontario (RNAO) – Toronto, ON
Cohort Representative/Member Responsibilities:
· Remains aware and up-to-date regarding RNAO’s operations, initiatives, strategic direction and critical issues that impact nursing, health and health care
Clinical Research Responsibilities:
Clinical Research Responsibilities:
Clinical Administrative and Research Responsibilities:
Clinical Research Responsibilities:
Clinical Research Responsibilities:
Fulcrum Therapeutics, 2019-2022
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 24-Week, Parallel-Group Study of the Efficacy
and Safety of Losmapimod in Treating Subjects with Facioscapulohumeral Muscular Dystrophy (FSHD)
Clinical Trial Name: FIS-002-2019
WinSanTor, Inc., 2019-2022
A Randomized, Double-Blind, Placebo-Controlled, Parallel, 24-Week, Phase 2a Study of Topical Pirenzepine
(WST-057) or Placebo in Type 2 Diabetic Patients with Peripheral Neuropathy
Clinical Trial Name: WST-PZP-002
University of Calgary, 2019-2022
A Phase II Randomized, Placebo-Controlled, Double-Blinded, Multi-Centre Clinical Trial of Pimozide in
Patients with Amyotrophic Lateral Sclerosis
Clinical Trial Name: Pimozide_ALS-002
Cytokinetics, 2021-2023
A Study to Evaluate Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis
(ALS)
Clinical Trial Name: COURAGE-ALS
Pharnext, 2021-2023
A Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study to Assess the Efficacy, Safety
and Tolerability of PXT3003 in Charcot-Marie-Tooth Type 1A (CMT1A)
Clinical Trials Name: PREMIER (CLN-PXT3003-06)
Janssen Research & Development, LLC., 2021-2023
Efficacy and Safety Study of Nipocalimab IV Infusions for Adults with Generalized Myasthenia Gravis
Clinical Trial Name: MOM-M281-011
Michael J. Fox Foundation, 2021-2036
The Parkinson's Progression Markers Initiative (PPMI) Clinical 2.0 - Establishing a Deeply Phenotyped PD Cohort
Clinical Trial Name: PPMI 2.0
Cerevel Therapeutics, 2021-2023
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, 27-Week Trial to Evaluate the Efficacy, Safety, and Tolerability of Two Fixed Doses of Tavapadon in Early Parkinson's Disease (TEMPO-01 Trial)
Clinical Trial Name: TEMPO-01
Cerevel Therapeutics, 2021-2024
58-Week Open-Label Trial of Tavapadon in Parkinson's Disease (TEMPO-04 Trial)
Clinical Trial Name: TEMPO-04
Ottawa Hospital Research Institute, 2018-2022
B3 for NMD: Bench to Bedside and Back Transformative discoveries leading to improved care in Neuromuscular Disease
Clinical Trial Name: B3 for NMD
Ottawa Hospital Research Institute, 2019-2023
A Prospective, Multi-center, Observational Study of the Safety, Tolerability, and Effectiveness of SPINRAZA in Adult Patients with Spinal Muscular Atrophy
Clinical Trial Name: Spinraza
Ottawa Hospital Research Institute, 2019-2022
Understanding Palliative care and End of Life Needs in ALS Population: The First Step to Improving Patient
and Caregiver Quality of Life
Clinical Trial Name: Palliative Care in ALS
study
Certifications
Soft Skills
Technical Skills
Published
Ceban F, Nogo D, Carvalho IP, Lee Y, Nasri F, Xiong J, Lui LMW, Subramaniapillai M, Gill H, Liu RN, Joseph P, Teopiz KM, Cao B, Mansur RB, Lin K, Rosenblat JD, Ho RC, McIntyre RS. Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2021 Jul 28:e211818. doi: 10.1001/jamapsychiatry.2021.1818. Epub ahead of print. PMID: 34319365; PMCID: PMC8319830.
Nogo D, Wilkialis L, Lui LMW, Nasri F, Rosenblat JD, McIntyre RS. Examining the association between
inflammation and motivational anhedonia in neuropsychiatric disorders: A systematic review. Ann Clin Psychiatry. 2021 Aug;33(3):193-206. doi: 10.12788/acp.0034. PMID: 34398735.
Nogo D, Nazal H, Song Y, Teopiz KM, Ho R, McIntyre RS, Lui LMW, Rosenblat JD. A Review of Potential Neuropathological Changes Associated with Ketamine. Expert Opin Drug Saf. 2022 Jun; 21(6): 813-831. doi: 10.1080/14740338.2022.2071867. Epub 2022 May 8.
Nogo D, Jasrai AK, Kim H, Nasri F, Ceban F, Lui LMW, Rosenblat JD, Vinberg M, Ho R, McIntyre RS. The Effect of Ketamine on Anhedonia: Improvements in Dimensions of Anticipatory, Consummatory, and Motivation-Related Reward Deficits. Psychopharmacology (Berl). 2022 Jul; 239(7): 2011-2039. doi: 10.1007/s00213-022-06105-9. Epub 2022 Mar 15.
Doyle MA, Lui LMW, Ho R, Di Vincenzo JD, Rosenblat JD, Gillissie ES, Nogo D, Ceban F, McIntyre RS. Hallucinogen Persisting Perceptual Disorder: A Systematic Review. Expert Opin Drug Saf. 2022 Jun; 21(6): 733-743. doi: 10.1080/14740338.2022.2063273. Epub 2022 May 3.
Zwicker J, Smith IC, Rice J, Murphy R, Breiner A, McNeely S, Duff M, Buenger U, Zehrt B, Nogo D, Watt CL. Palliative care at any stage of amyotrophic lateral sclerosis: a prospective feasibility study. Front Med (Lausanne). 2023 Sep 13;10:1204816. doi: 10.3389/fmed.2023.1204816. PMID: 37780560; PMCID: PMC10533918.
Submitted Manuscripts
Kahn Z, El-Halabi, Nogo D, Lokuge S, Fotinos K, Mason G, Katzman MA. The association between nicotine
and the reward circuit: Relevant to the neurobiology of attention-deficit/hyperactivity disorder and major
depressive disorder. Submitted in 2023.
Watt CL, Smith IC, Rice J, Murphy R, Breiner A, Duff M, Nogo D, Bush SH, McNeely S, Buenger U, Zehrt B, Zwicker J. Qualitative analysis of palliative care consultations in amyotrophic lateral sclerosis: insights for physicians and informal caregivers. Sumbitted in 2023.
Presentations
A Review of Potential Neuropathological Changes Associated with Ketamine in Human and Animal Studies. 2021. Mood Disorders Psychopharmacology Unit/Canadian Rapid Treatment Center of Excellence Research Conference. (Toronto, Canada)
Dotsa Bitove Wellness Academy, 02/2020 to 06/2020
University Health Network with York University - Toronto, Ontario
Canadian Students for Sensible Drug Policy, 09/2019 to 12/2019
Ryerson University - Toronto, Ontario
Tutor, 06/2018 to 09/2019
Tutor Doctor Central Toronto - Toronto, Ontario
Hospital Volunteer, 07/2014 to 08/2018
Sunnybrook Health Sciences Centre - Toronto, Ontario
Community Placement Student, 01/2024 to 04/2024
BGC West Scarborough/Claude Watson School for the Arts – Toronto, ON
· Under the supervision of Kyle Rhodius, Children and Youth Services Coordinator
Clinical Research Responsibilities:
· Conducted strengths-based HEIA assessment of the Claude Watson community
· Evaluated children in needs related to SDOH community care
· Assisted children in weekly after-school homework help, play and physical activity plans
· Developed and coordinated implementation of learning plan towards mental health education, tools, and improving social connectedness of community and family-centered care